EA
MDT icon

Emerald Advisers’s Medtronic MDT Stock Holding History

Emerald Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,596
Closed -$229K – 389
2014
Q2 		$229K Sell
3,596
-339
-9% -$20.6K 0.01% 336
2014
Q1 		$242K Sell
3,935
-876
-18% -$51K 0.01% 329
2013
Q4 		$276K Buy
4,811
+343
+8% +$19.4K 0.01% 316
2013
Q3 		$238K Sell
4,468
-303
-6% -$16.3K 0.01% 324
2013
Q2 		$246K Buy
+4,771
New +$236K 0.02% 312

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Emerald Advisers's MDT Position: Q3 2014 in Review

Emerald Advisers sold out of Medtronic (MDT) in Q3 2014, closing a stake of 3,596 shares — an estimated $229K sold.

Emerald Advisers first reported a position in MDT in Q2 2013 and held it in 5 quarters. The position peaked at $276K in Q4 2013. 1,134 funds tracked by Wall St. Rank hold MDT as of Q3 2014.

  • Emerald Advisers reported no remaining Medtronic position as of Q3 2014 after selling out during the quarter.
  • Emerald Advisers sold 3,596 Medtronic shares in Q3 2014, an estimated $229K.
  • Emerald Advisers first reported a position in Medtronic in Q2 2013 and held it in 5 quarters.
  • Emerald Advisers's Medtronic position peaked at $276K in Q4 2013.
  • 1,134 funds tracked by Wall St. Rank held Medtronic as of Q3 2014.

Based on Emerald Advisers's 13F filing for Q3 2014, filed 28 Oct 2014.